Silo Pharma
SILO
11 hedge funds and large institutions have $371K invested in Silo Pharma in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
215% more capital invested
Capital invested by funds: $118K → $371K (+$253K)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
22% more funds holding
Funds holding: 9 → 11 (+2)
0.29% more ownership
Funds ownership: 0.22% → 0.5% (+0.29%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$322K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$20.4K |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$8.52K |
| 5 |
Lazard Asset Management
New York
|
+$1.45K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$23.9K |
| 2 |
VF
Virtu Financial
New York
|
-$23.1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.69K |
| 4 |
RWMG
Redwood Wealth Management Group
Medford,
New Jersey
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $250K | +$322K | +15,134 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $33.8K | +$20.7K | +972 | +90% |
|
|
VF
3
Virtu Financial
New York
| $28K | -$23.1K | -1,082 | -39% |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $18K | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| $15.8K | +$20.4K | +958 | New |
|
6
State Street
Boston,
Massachusetts
| $13.8K | – | – | – |
|
|
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $6.6K | +$8.52K | +400 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $4.47K | -$3.69K | -173 | -39% |
|
|
9
Lazard Asset Management
New York
| $1K | +$1.45K | +68 | New |
|
|
WIM
10
Westside Investment Management
Santa Monica,
California
| $103 | – | – | – |
|
11
Bank of America
Charlotte,
North Carolina
| $40 | +$21 | +1 | +100% |
|
12
JP Morgan Chase
New York
| $1 | – | – | – |
|
|
FAIM
13
Financial Advocates Investment Management
Olympia,
Washington
| – | -$23.9K | -1,596 | Closed |
|
|
RWMG
14
Redwood Wealth Management Group
Medford,
New Jersey
| – | -$2K | -133 | Closed |
|
SILO Hedge Fund Activity: Q3 2024 in Review
11 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q3 2024, worth a combined $371K — up 215% from $118K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SILO positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $322K. The largest seller was Financial Advocates Investment Management, exiting entirely with an estimated $23.9K sold.
- 11 institutional investors held Silo Pharma (SILO) as of Q3 2024, up from 9 in Q2 2024.
- Funds reported $371K of Silo Pharma stock for Q3 2024, up 215% quarter-over-quarter.
- 4 funds opened new Silo Pharma positions in Q3 2024 and 2 closed out, a net change of +2 holders.
- The largest Silo Pharma buyer in Q3 2024 was Renaissance Technologies, an estimated $322K added.
- The largest Silo Pharma seller in Q3 2024 was Financial Advocates Investment Management, an estimated $23.9K sold.
Based on aggregated 13F filings for Q3 2024.